The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells

Both erbB3 and IGF-1 receptor (IGF-1R) have been shown to play an important role in trastuzumab resistance. However, it remains unclear whether erbB3- and IGF-1R-initiated signaling pathways possess distinct effects on the sensitivity of lapatinib, a dual tyrosine kinase inhibitor against both EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Hui, Yang, Xiao He, Edgerton, Susan M., Thor, Ann D., Wu, Xiaoying, He, Zhimin, Liu, Bolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823081/
https://www.ncbi.nlm.nih.gov/pubmed/26621843
http://dx.doi.org/10.18632/oncotarget.6404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823081/
https://www.ncbi.nlm.nih.gov/pubmed/26621843
http://dx.doi.org/10.18632/oncotarget.6404

Ejemplares similares